Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

@article{Halasa2015SafetyAI,
  title={Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.},
  author={Natasha B Halasa and Michael A. Gerber and Andrea A. Berry and Edwin L. Anderson and Patricia L. Winokur and Harry L. Keyserling and Allison Ross Eckard and Heather R Hill and Mark C Wolff and Monica M Mcneal and Kathryn Margaret Edwards and David I. Bernstein},
  journal={Journal of the Pediatric Infectious Diseases Society},
  year={2015},
  volume={4 3},
  pages={214-24}
}
BACKGROUND Children 6 through 35 months of age are recommended to receive half the dose of influenza vaccine compared with older children and adults. METHODS This was a 6-site, randomized 2:1, double-blind study comparing full-dose (0.5 mL) trivalent inactivated influenza vaccine (TIV) with half-dose (0.25 mL) TIV in children 6 through 35 months of age. Children previously immunized with influenza vaccine (primed cohort) received 1 dose, and those with no previous influenza immunizations… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
Safety and Immunogenicity of Full - Dose Trivalent Inactivated Influenza Vaccine ( TIV ) Compared With Half - Dose TIV Administered to Children 6 Through 35 Months of Age .
This was a 6-site , randomized 2:1 , double - blind study comparing full - dose ( 0.5 mL ) trivalent inactivated influenza vaccine ( TIV ) with half - dose ( 0.25 mL ) TIV in children 6 through 35 months of age .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
Children previously immunized with influenza vaccine ( primed cohort ) received 1 dose , and those with no previous influenza immunizations ( naive cohort ) received 2 doses of TIV .
All Topics